At a median follow-up of 21.5 months, ADT plus apalutamide significantly prolonged median PSA progression-free survival compared with ADT monotherapy (24.9 vs 20.3 months; hazard ratio [HR], 0.52).
In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate cancer considered to be “intermediate risk” — mostly, small tumors confined to one ...
Testing for High-Risk Human Papillomavirus in Lower Genital Tract Tumors: If Knowledge Does Not Translate to an Action That Helps Patients—Why Do It? A substantial number of anticancer drugs receive ...
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
Please provide your email address to receive an email when new articles are posted on . An educational video increased awareness for Black men about their risk for prostate cancer. Viewers described ...
Age, race and family history are the only well-established risk factors for prostate cancer, one of the commonest types of cancer in developed countries (Hsing and Devesa, 2001; Grönberg, 2003). Cases ...
Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...
High-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation. In recent years, a new treatment strategy known as focal therapy (partial gland ablation) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results